Overview

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Status:
COMPLETED

Trial end date:
2025-08-29

Target enrollment:

Participant gender:

Summary

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Phase:

PHASE4

Details

Lead Sponsor:

Blue Earth Diagnostics

Collaborator:

Aixial Group